Approval · Notice of Compliance 16163 · 2014
AERIUS: Notice of Compliance 16163
Issued April 1, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16163
- Date
- April 1, 2014
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Broadening therapeutic indication to include the treatment of perennial allergic rhinitis (par) for adults and children 2 years and above
- Therapeutic class
- Histamine h1 receptor antagoniste
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AERIUS | Not yet assigned | — |
| AERIUS KIDS | Not yet assigned | — |
Medicinal ingredients
- DESLORATADINE 0.5 MG per ML